
Dear Investors, Partners, and Esteemed Customers,
As Chairman of Virgil Healthcare, advancing healthcare through Innovation & trust, it is both a privilege and a responsibility to guide a company at the forefront of diagnostic innovation. Today, I write to share our vision, celebrate our collective achievements, and reaffirm our commitment to transforming healthcare through high-speed precision, accessibility, and technological excellence.
The Virgil Promise: Where Vision Meets Impact
Healthcare is evolving rapidly, and diagnostics lie at its heart. At Virgil, we recognize that accurate, timely, and affordable testing is not just a medical necessity—it is a fundamental human right. Our mission is to democratize access to world-class diagnostics, ensuring that every patient, in every corner of the world, benefits from cutting-edge science.
For our investors, Virgil represents a rare convergence of social impact and sustainable growth. Our patented OnS!te® Minilabs and AI-driven cancer diagnostics are not just breakthroughs; they are scalable solutions addressing critical gaps in global healthcare. With FDA/CE approvals, strategic alliances, and a pipeline of disruptive technologies, we are poised to redefine the diagnostics landscape.
To our customers and partners, we extend our deepest gratitude. Your trust inspires us to push boundaries daily. Whether you are a clinician relying on our rapid POC tests, a researcher leveraging our biomarkers, or a hospital system integrating our platforms, your success is our ultimate metric.
Excited to be ahead of Strategic Growth
- Global Expansion: Launching OnS!te® Minilabs in 10+ emerging markets, bringing 15-minute diagnostics to underserved regions.
- Cancer Screening Revolution: Partnering with governments and NGOs to deploy our AI oncology platform for early detection in high-risk populations.
- Sustainability Leadership: Reducing diagnostic waste by 30% through eco-conscious lab design and reusable components.
Our Pillars of Excellence
- Innovation Without Compromise: From CLIA-waived tools to genomic sequencing, we invest in the future.
- Ethical Stewardship: Prioritizing patient privacy (HIPAA/GDPR-compliant) and equitable pricing.
- Collaborative Leadership: Working hand-in-hand with clinicians, policymakers, and communities to solve real-world challenges.
A Call to Collective Action
The road ahead is both exciting and demanding. To our investors, we invite you to deepen your engagement—explore our pipeline, visit our labs, and join our mission. To our customers, we pledge relentless improvement; your feedback is our compass.
Together, we can turn the promise of high-speed precision healthcare into a reality for millions. Learn more at www.virgilhealthcare.com or connect with me at info@virgilhealthcare.com.
With unwavering commitment,
Dr. Harshavardhan Hegde
Chairman of the Board
Virgil Healthcare
Diagnostics with Integrity……..Innovation with Purpose.

Dear Valued Investors, Customers, Partners, and Team,
At Virgil Healthcare, pioneering the future of diagnostics, we stand at the intersection of innovation and impact, driven by a singular mission: to transform global healthcare through precision and high-speed diagnostics. As CEO, I am honored to share our vision, progress, and unwavering commitment to advancing medical testing for clinicians, patients, and communities worldwide.
In an era where timely and accurate diagnostics can mean the difference between life and death, we are redefining what’s possible. Our cutting-edge high speed diagnostic solutions—from rapid point-of-care testing (OnS!te® Minilabs) to AI-powered cancer screening—are designed to bridge critical gaps in healthcare access, speed, and affordability.
For our investors, Virgil represents a unique opportunity to back a company that combines breakthrough technology with scalable impact. Our patented biomarkers, CLIA-waived platforms, and strategic partnerships position us to lead the next wave of diagnostic innovation—with measurable clinical and financial returns. Thank you for your trust and partnership. Your support enables us to push boundaries, invest in groundbreaking research, and deliver sustainable growth.
For customers and partners, we pledge reliability, speed, and actionable insights. Whether you’re a hospital seeking faster turnaround times, a rural clinic overcoming resource constraints, or a researcher pushing the boundaries of precision medicine, Virgil is your trusted ally.
And to our employees, your dedication is our greatest strength. Your passion and expertise drive our success—thank you for making Virgil Healthcare a leader in our industry.
As we look ahead, we remain steadfast in our mission, guided by integrity and a vision for transformative impact. The road forward is filled with opportunity, and I am grateful to have you alongside us.
Our Milestones
- Expanding Access: Deploying OnS!te® Minilabs across 500+ clinics in underserved regions, delivering results in under 15 minutes.
- Cancer Detection Breakthroughs: Scaling our AI-driven oncology platform to screen 1 million patients annually for early-stage cancers.
- Global Partnerships: Collaborating with FDA/CE-approved leaders to bring best-in-class diagnostics to new markets.
A Commitment to Excellence
- Quality First: Every test meets the highest standards of accuracy (CLIA/ISO-certified labs).
- Patient-Centric Design: Affordable, user-friendly solutions for equitable care.
- Sustainability: Reducing healthcare’s environmental footprint through efficient, low-waste systems.
Join us as we build a future where no patient waits for answers, no disease goes undetected, and no community is left behind. Explore our latest advancements at www.virgilhealthcare.com or reach me directly at info@virgilhealthcare.com.
With gratitude and resolve,
Venkatesh Kallur
Chief Executive Officer & Board Member
Virgil Healthcare
High-speed Precision Diagnostics………….Empowering Lives
Our Professional Team
A dedicated group of experts committed to delivering exceptional
service and unparalleled results

Dr. Rohit Dwivedi

Dr. Rohit Dwivedi - M.D, Phoenix, Arizona, USA
Experienced Clinician with demonstrated history of working in the Medical Industry. Seasoned professional skilled in Clinical Research, Medical Education and Clinical Medicine.
A graduate of the The Ohio State University College of Medicine, he completed his post-graduate training and Endocrinology fellowship at Indiana University.
He has been in practice for over 20 years and has run a CLIA-certified physician laboratory for over 15 years. He has extensive ties with the medical industry as Chief Medical Officer of numerous organizations, consultant with Silicon Valley firms, such as Medikarma.ai and has been involved in the startup of other companies.

Rahul Bhattacharya

Rahul Bhattacharya - Board Member
Co-founder of Microgravity Ventures with 24 years of corporate experience, including 11 years at Accenture India.
Built a gaming. enterprise from scratch
He managed P&L through multiple sales and operating cycles for innovation led start-ups and professional services firm for
clients in India, APAC, Middle East and Americas.
He has successfully Incubated & managed new products and innovation. He carries cross-industry complex deal-making expertise – Telecom, Technology, Financial Services and Government. His other strengths being in Client relationship and solving for growth and profitability challenges, Establish Strategic partnerships and alliances and Spearheading Business Transformation, Strategic Outsourcing and Value Based programs.

Dr. Ashok Vaid

Dr. Ashok Vaid - Board Member
Oncology Chairman at Medanta Group with a distinguished career in cancer care. A Padma Shri Awardee for his contributions to Medicine, Dr. Ashok Vaid is a renowned medical oncologist, known for his pioneering efforts in bone marrow transplantation in India. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India.
Dr. Ashok Vaid is an Oncologist/Cancer Specialist with 28 years of expertise in this profession. He earned an MBBS from the University of Jammu in 1984, an MD in Internal Medicine from the same university in 1989, and a DM in Oncology from Dr. MGR Medical University in Chennai, India, in 1993.
Furthermore, he has decades of clinical experience, with a focus on cancer genomics, immunotherapy guidance, and precision onco-therapeutics, as well as dendritic cell treatment and stem cell transplantation. Meanwhile, he is a postgraduate instructor registered with the National Board of Examinations and serves on the panel of university examiners for the super-specialty course Medical Oncology.

Venkatesh Kallur

Venkatesh Kallur - Chief Executive Officer & Board Member
Venkatesh Kallur is a distinguished figure in the international banking, financial and healthcare services sectors, known for his extensive expertise in strategy & operational management. Over a career spanning more than three decades, Mr. Kallur has built a reputation for his deep understanding of financial management and data resilience. He has served in high-level positions, such as Chief Executive Officer (CEO), Chief Risk Officer (CRO), and Advisor where he has been responsible for overseeing management strategies in large financial and HealthCare institutions.
Professional Roles:
In his executive roles, Mr. Kallur primarily focuses on ensuring that his various organizations are prepared to manage strategy and mitigate risks, including those arising from digital transformations and supply chain management. His approach involves a blend of strategic foresight, operational rigor, and an emphasis on developing a strong and sustainable infrastructure along with second line management.
Beyond his executive roles, Mr. Kallur is well-regarded in Thought Leadership, Mentorship, & Coaching. He frequently participates in international conferences and forums, where he shares insights in managing risks across large healthcare project management, the importance of data science in the healthcare & financial sector, along with the challenges posed by rapid technological advancements. His contributions to these discussions emphasize the need for financial and healthcare institutions to be proactive in their risk management practices, particularly in the face of evolving cyber threats. He is known for his ability to guide and inspire the next generation of professionals in the healthcare and financial sector, helping them navigate the complexities of strategic management and leadership. His work is widely recognized in various industry publications and platforms that focus on sustainability, supply chain management, and data center management, underscoring his broad influence across different sectors.

Dr. Harshavardhan Hegde

Dr. Harshavardhan Hegde - Chairman of the Board
Director and leading Orthopaedic surgeon, with the Max Group of Hospitals. Practice in India and the Middle-east.
With over 3 decades of experience post M.S.(Ortho), which he completed from Baroda Medical College in 1987, he gathered clinical experience overseas with fellowships in prestigious institutions like Nuffield Orthopedic Centre in Oxford, UK and Klinikum Karlsbaad, Germany - one of world’s premier institution for spinal surgery. I have also undertaken specific specialist training in US, Australia, Brussels and Budapest.
In India, he taught undergraduate and post graduate students in Pramukh Swami Medical College at Karamsad Gujarat where he served as the Professor & Head of Orthopedics. After heading the Orthopedic units in Alembic Hospital, Vadodara and Apollo Hospital in Gandhinagar, he moved to New Delhi in 2005 with Max Hospitals at Patparganj and have done stints at multiple corporate hospitals in the city eg Artemis Hospital Gurgaon, Nova Bone & Joint Hospital and Fortis Vasant Kunj. Dr.Hegde is one of the first persons in the country to do robotic spinal surgery in 2013. He is a regular visitor to the Sultanate of Oman for over a decade as a Senior Consultant, Spine & Orthopedics. He operated extensively in Middle East, Iraq and Africa and have a large patient base from these countries.